Arizona Cancer Center [clinicaltrials_resource:df0fa7c8a9c07f507c623cb55ae89f49]
Microarray Analysis for Human Genetic Disease [clinicaltrials:NCT00001898]Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer [clinicaltrials:NCT00002659]High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer [clinicaltrials:NCT00003068]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse [clinicaltrials:NCT00003131]clinicaltrials:NCT00003223Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer [clinicaltrials:NCT00003307]Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003415]clinicaltrials:NCT00003671CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse [clinicaltrials:NCT00003673]clinicaltrials:NCT00003783clinicaltrials:NCT00003787SR-45023A in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003822]Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer [clinicaltrials:NCT00004202]Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00020800]Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis [clinicaltrials:NCT00021294]Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00023868]Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00024284]Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer [clinicaltrials:NCT00031187]Phase 2 Study of TLK286 in Metastatic Breast Cancer [clinicaltrials:NCT00035841]Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [clinicaltrials:NCT00039052]Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer [clinicaltrials:NCT00040170]Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00040638]A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies [clinicaltrials:NCT00043199]Phase II Trial of Allovectin-7® for Metastatic Melanoma [clinicaltrials:NCT00044356]Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00044382]Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma [clinicaltrials:NCT00050102]Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer [clinicaltrials:NCT00051584]Vaccine Therapy for Patients With Stage III Melanoma [clinicaltrials:NCT00052130]Vaccine Therapy for Patients With Stage IV Melanoma [clinicaltrials:NCT00052156]clinicaltrials:NCT00094653Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer [clinicaltrials:NCT00102752]Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies [clinicaltrials:NCT00129337]Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) [clinicaltrials:NCT00285259]Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma [clinicaltrials:NCT00289640]A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer [clinicaltrials:NCT00320255]Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer [clinicaltrials:NCT00372073]clinicaltrials:NCT00377429Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma [clinicaltrials:NCT00383851]A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia [clinicaltrials:NCT00419250]
location [clinicaltrials_vocabulary:location]
Arizona Cancer Center [clinicaltrials_resource:df0fa7c8a9c07f507c623cb55ae89f49]
Bio2RDF identifier
df0fa7c8a9c07f507c623cb55ae89f49
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:df0fa7c8a9c07f507c623cb55ae89f49
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:df0fa7c8a9c07f507c623cb55ae89f49
title
Arizona Cancer Center
@en
type
label
Arizona Cancer Center [clinicaltrials_resource:df0fa7c8a9c07f507c623cb55ae89f49]
@en